Sort   by:  
 Page size 
UnknownEffects of Tablet Formulation, Food, or Gastric pH on the Bioavailability of Asundexian.
Not available
S-EPMC10107294 | biostudies-literature
UnknownPopulation Pharmacokinetics of Asundexian in People at Risk for Thromboembolic/Cardiovascular Events.
Not available
S-EPMC12823300 | biostudies-literature
UnknownEffect of Age, Sex, Renal Impairment and Hepatic Impairment on the Safety, Pharmacokinetics and Pharmacodynamics of Asundexian.
Not available
S-EPMC11573861 | biostudies-literature
UnknownPharmacokinetics, pharmacodynamics, and safety of asundexian in healthy Chinese and Japanese volunteers, and comparison with Caucasian data.
Not available
S-EPMC11289896 | biostudies-literature
UnknownFirst evaluation of the safety, pharmacokinetics, and pharmacodynamics of BAY 2433334, a small molecule targeting coagulation factor XIa.
Not available
S-EPMC8518835 | biostudies-literature
UnknownPharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple-dose study.
Not available
S-EPMC9311154 | biostudies-literature
UnknownMetabolism and Disposition of the Novel Oral Factor XIa Inhibitor Asundexian in Rats and in Humans.
Not available
S-EPMC10322790 | biostudies-literature
UnknownPopulation Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib-Treated Cancer.
Not available
S-EPMC5613186 | biostudies-literature
Sort   by:  
 Page size